Health
Investigational Alzheimer’s drug reduces molecular markers of the disease – News-Medical.Net
An investigational Alzheimer’s drug reduced molecular markers of disease and curbed neurodegeneration in the brain, without demonstrating…
An investigational Alzheimer’s drug reduced molecular markers of disease and curbed neurodegeneration in the brain, without demonstrating evidence of cognitive benefit, in a phase 2/3 clinical trial led by researchers at Washington University School of…
Continue Reading
-
Noosa News21 hours agoNoosa Council targeted in fraud
-
Noosa News21 hours agoDavid’s neighbour died alone. He now knows what comes next
-
General24 hours agoACT family violence victims ‘waiting 3 or 4 days’ for help, inquiry hears
-
Noosa News23 hours agoFarmer gives chase after gun pulled in Scenic Rim quad bike theft